Latest Monoclonal antibodies Stories
Supports progression of this first-in-class anti-TLR4 monoclonal antibody into clinical proof of concept study as a potential personalized medicine for rheumatoid arthritis GENEVA, August
MONROVIA, Calif., Aug. 5, 2014 /PRNewswire/ -- Xencor, Inc.
TARRYTOWN, N.Y. and PARIS, July 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
The factors contributing to sample preparation market growth are the improvements in the funding scenario globally, increase in the number of government sponsored research activities, and developments
Three new tools for bacterial detection and isolation MILFORD, Mass., July 29, 2014 /PRNewswire/ -- KPL, a SeraCare Company, today announced the addition of three new products to its
Emerging Therapies, Especially IL-17 Inhibitors, Have Potential Relative to Current Therapies in Improving Psoriatic Plaques, According to Findings from Decision Resources Group BURLINGTON,
While Expressing Concerns about Reimbursement, EU5 Payers Look Favorably on Identifying Anti-IL5 Therapy-Responsive Patients, According to Findings from Decision Resources Group BURLINGTON,
MONROVIA, Calif., July 24, 2014 /PRNewswire/ -- Xencor, Inc.
Genzyme/Sanofi's Lemtrada and Genentech/Roche's Ocrelizumab Will Likely Be Reserved for Patients with Aggressive/Severe MS, According to Findings from Decision Resources Group BURLINGTON, Mass.,
LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- A serpent whose bite was fabled to produce intense thirst.
More Images (1 images) »